Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Inhibitors of sCD23 production developed at SmithKline Beecham

Sep. 30, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Arris reports data from phase IIa asthma trial

Sep. 26, 1997

CMI-947: new 5-LO inhibitor discovered at CytoMed

Sep. 26, 1997

Synthetic studies on LAS-32521 reported

Sep. 26, 1997

Novel benzothiazolone ethanamines for airways diseases

Sep. 26, 1997

Labeling changes for Seldane products

Sep. 25, 1997

Yamanouchi develops potent and selective PDE IV inhibitors

Sep. 25, 1997

Anti-IgE MAb progresses to late-stage clinical trials in asthma

Sep. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.